{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T11:53:55Z","timestamp":1790855635067,"version":"4.1.0"},"reference-count":16,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2025,1,18]],"date-time":"2025-01-18T00:00:00Z","timestamp":1737158400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,1,18]],"date-time":"2025-01-18T00:00:00Z","timestamp":1737158400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Ann Hematol"],"published-print":{"date-parts":[[2025,3]]},"DOI":"10.1007\/s00277-025-06206-3","type":"journal-article","created":{"date-parts":[[2025,1,17]],"date-time":"2025-01-17T22:54:13Z","timestamp":1737154453000},"page":"1995-2000","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":8,"title":["Epcoritamab-Induced fatal pleural effusion in diffuse large B-Cell lymphoma: a case report and literature review"],"prefix":"10.1007","volume":"104","author":[{"ORCID":"https:\/\/orcid.org\/0009-0006-7524-9339","authenticated-orcid":false,"given":"Atsushi","family":"Takahata","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tomohito","family":"Shimada","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kana","family":"Bando","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shigeo","family":"Toyota","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,1,18]]},"reference":[{"key":"6206_CR1","doi-asserted-by":"publisher","first-page":"102625","DOI":"10.1016\/j.ebiom.2019.102625","volume":"52","author":"PJ Engelberts","year":"2020","unstructured":"Engelberts PJ, Hiemstra IH, de Jong B et al (2020) DuoBody-CD3xCD20 induces potent T-cell-mediated killing of malignant B cells in preclinical models and provides opportunities for subcutaneous dosing. EBioMedicine 52:102625","journal-title":"EBioMedicine"},{"issue":"16","key":"6206_CR2","doi-asserted-by":"publisher","first-page":"1800","DOI":"10.1182\/blood-2017-03-769620","volume":"130","author":"M Crump","year":"2017","unstructured":"Crump M, Neelapu SS, Farooq U et al (2017) Outcomes in refractory diffuse large B-cell lymphoma: results from the international SCHOLAR-1 study. Blood 130(16):1800\u20131808","journal-title":"Blood"},{"issue":"12","key":"6206_CR3","doi-asserted-by":"publisher","first-page":"2238","DOI":"10.1200\/JCO.22.01725","volume":"41","author":"C Thieblemont","year":"2023","unstructured":"Thieblemont C, Phillips T, Ghesquieres H et al (2023) Epcoritamab, a Novel, Subcutaneous CD3xCD20 Bispecific T-Cell-engaging antibody, in relapsed or refractory large B-Cell lymphoma: dose expansion in a phase I\/II trial. J Clin Oncol 41(12):2238\u20132247","journal-title":"J Clin Oncol"},{"key":"6206_CR4","doi-asserted-by":"publisher","first-page":"188","DOI":"10.1182\/blood-2014-05-552729","volume":"124","author":"DW Lee","year":"2014","unstructured":"Lee DW, Gardner R, Porter DL et al (2014) Current concepts in the diagnosis and management of cytokine release syndrome. Blood 124:188\u2013195","journal-title":"Blood"},{"issue":"14","key":"6206_CR5","doi-asserted-by":"publisher","first-page":"7652","DOI":"10.3390\/ijms22147652","volume":"22","author":"M Cosenza","year":"2021","unstructured":"Cosenza M, Sacchi S, Pozzi S (2021) Cytokine release Syndrome Associated with T-Cell-based therapies for hematological malignancies: pathophysiology, clinical presentation, and treatment. Int J Mol Sci 22(14):7652","journal-title":"Int J Mol Sci"},{"issue":"1","key":"6206_CR6","doi-asserted-by":"publisher","first-page":"134","DOI":"10.1038\/s41392-020-00256-x","volume":"5","author":"J Wei","year":"2020","unstructured":"Wei J, Liu Y, Wang C et al (2020) The model of cytokine release syndrome in CAR T-cell treatment for B-cell non-hodgkin lymphoma. Signal Transduct Target Ther 5(1):134","journal-title":"Signal Transduct Target Ther"},{"issue":"3","key":"6206_CR7","doi-asserted-by":"publisher","first-page":"104","DOI":"10.1097\/CJI.0000000000000160","volume":"40","author":"JL Tanyi","year":"2017","unstructured":"Tanyi JL, Stashwick C, Plesa G et al (2017) Possible compartmental cytokine release syndrome in a patient with recurrent ovarian Cancer after treatment with mesothelin-targeted CAR-T cells. J Immunother 40(3):104\u2013107","journal-title":"J Immunother"},{"issue":"7","key":"6206_CR8","doi-asserted-by":"publisher","first-page":"e9992","DOI":"10.1097\/MD.0000000000009992","volume":"97","author":"L Ding","year":"2018","unstructured":"Ding L, Hu Y, Zhao K et al (2018) Pleural cavity cytokine release syndrome in CD19-directed chimeric antigen receptor-modified T cell therapy: a case report. Med (Baltim) 97(7):e9992","journal-title":"Med (Baltim)"},{"issue":"7","key":"6206_CR9","doi-asserted-by":"publisher","first-page":"969","DOI":"10.1038\/s41409-018-0412-1","volume":"54","author":"A Jin","year":"2019","unstructured":"Jin A, Feng J, Wang Z et al (2019) Severe dyspnea caused by rapid enlargement of cervical lymph node in a relapsed\/refractory B-cell lymphoma patient following chimeric antigen receptor T-cell therapy. Bone Marrow Transpl 54(7):969\u2013972","journal-title":"Bone Marrow Transpl"},{"key":"6206_CR10","doi-asserted-by":"crossref","unstructured":"Luan C, Zhou J, Wang H et al Case Report: local cytokine release syndrome in an Acute Lymphoblastic Leukemia Patient after Treatment with chimeric Antigen receptor T-Cell therapy: a possible model, Literature Review and Perspective. Front Immunol 2021 Jul 19:12707191","DOI":"10.3389\/fimmu.2021.707191"},{"issue":"1","key":"6206_CR11","doi-asserted-by":"publisher","first-page":"257","DOI":"10.1159\/000522669","volume":"15","author":"H Shima","year":"2022","unstructured":"Shima H, Kurosawa T, Oikawa H et al (2022) Cervical edema extending to the larynx as local Cytokine Release Syndrome following chimeric Antigen receptor T-Cell therapy in a boy with refractory Acute Lymphoblastic Leukemia. Case Rep Oncol 15(1):257\u2013262","journal-title":"Case Rep Oncol"},{"key":"6206_CR12","doi-asserted-by":"crossref","unstructured":"Moriyama S, Fukata M, Yokoyama T et al (2022 Mar) Case Report: Cardiac Tamponade in Association with Cytokine Release Syndrome following CAR-T cell therapy. Front Cardiovasc Med 21:9848091","DOI":"10.3389\/fcvm.2022.848091"},{"issue":"5","key":"6206_CR13","doi-asserted-by":"publisher","first-page":"647","DOI":"10.1007\/s12185-023-03633-8","volume":"118","author":"Y Nakanishi","year":"2023","unstructured":"Nakanishi Y, Marumo Y, Ri M, Kinoshita S et al (2023) Laryngeal edema as a symptom of local cytokine release syndrome after BCMA-targeting CAR-T therapy for relapsed and refractory multiple myeloma. Int J Hematol 118(5):647\u2013651","journal-title":"Int J Hematol"},{"issue":"41","key":"6206_CR14","doi-asserted-by":"publisher","first-page":"e35432","DOI":"10.1097\/MD.0000000000035432","volume":"102","author":"HH Chen","year":"2023","unstructured":"Chen HH, Kuo CY, Ho CL et al (2023) Chylothorax after chimeric antigen receptor T cell therapy for relapsed and refractory diffuse large B-cell lymphoma: a case report. Med (Baltim) 102(41):e35432","journal-title":"Med (Baltim)"},{"key":"6206_CR15","doi-asserted-by":"crossref","unstructured":"Sarfati S, Eug\u00e8ne Norbert M, H\u00e9rault A et al (2023 Mar) Case report: CAR-T cell therapy-induced cardiac tamponade. Front Cardiovasc Med 20:101132503","DOI":"10.3389\/fcvm.2023.1132503"},{"issue":"5","key":"6206_CR16","first-page":"e38905","volume":"15","author":"Y Inoue","year":"2023","unstructured":"Inoue Y, Fujino T, Chinen S et al (2023) Cervical local cytokine release syndrome following chimeric Antigen receptor T-cell therapy in patients with relapsed or refractory diffuse large B-cell lymphoma. Cereus 15(5):e38905","journal-title":"Cereus"}],"container-title":["Annals of Hematology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00277-025-06206-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00277-025-06206-3\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00277-025-06206-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,4,25]],"date-time":"2025-04-25T06:11:04Z","timestamp":1745561464000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00277-025-06206-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,1,18]]},"references-count":16,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2025,3]]}},"alternative-id":["6206"],"URL":"https:\/\/doi.org\/10.1007\/s00277-025-06206-3","relation":{"has-preprint":[{"id-type":"doi","id":"10.21203\/rs.3.rs-4774078\/v1","asserted-by":"object"}]},"ISSN":["0939-5555","1432-0584"],"issn-type":[{"value":"0939-5555","type":"print"},{"value":"1432-0584","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,1,18]]},"assertion":[{"value":"20 July 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 January 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 January 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Written informed consent was obtained from the patient for the publication of this case report and any accompanying images.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Patient consent statement"}},{"value":"The authors declare no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}